21.01.2026
Artificial intelligence in medicine: the turning point is here.
Five years ago, AI in medicine sounded like a promise. Today, it’s becoming an industry.
Google has just crossed a decisive threshold, Isomorphic Labs is preparing clinical trials, and AI-designed drugs could shrink a 15-year process to a matter of months. This is no longer about algorithms supporting research – it’s about redefining how medicine is discovered, tested, and delivered.
Behind the technology lies a massive economic shift: healthcare, data, code, and capital are converging. For patients, it means faster treatments. For pharma, a new operating model. For investors, a frontier that is just opening.
Watch the video by John Plassard, Partner & Head of Investment Strategy at Cité Gestion!
More articles
01.04.2026
How to navigate uncertainty?
Volatility is shaping markets, but investors may be underestimating future risks.
Read more30.03.2026
Appointment of two new partners at Cité Gestion
We are delighted to announce the appointment of Africa Bootello and Joëlle Garcia as partners.
Read more19.03.2026
Welcome to Yulia Romantseva!
We are pleased to share the arrival of Yulia Romantseva as a Banker at Cité Gestion.
Read more17.03.2026
Is the worst nightmare of central banks (and investors) making a comeback?
The resurgence of geopolitical tensions and higher oil prices has brought the risk of stagflation back into focus, posing new challenges for central banks and investors.
Read more10.03.2026
Welcome to Johan Leën!
We are pleased to announce the arrival of Johan Leën as a Banker at Cité Gestion.
Read more03.03.2026
Crisis Reflex: how do markets react to tensions in the Middle East?
Geopolitical tensions in the Middle East are shaking markets, though the turmoil may prove short-lived rather than transformative.
Read more